Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology | 29 | 2022 | 190 | 9.180 |
Why?
|
Education, Medical | 9 | 2023 | 229 | 2.530 |
Why?
|
Education, Medical, Undergraduate | 8 | 2023 | 158 | 2.500 |
Why?
|
Anatomy | 5 | 2017 | 20 | 2.440 |
Why?
|
Radiologists | 6 | 2022 | 40 | 2.050 |
Why?
|
Curriculum | 15 | 2022 | 527 | 1.980 |
Why?
|
Students, Medical | 10 | 2022 | 381 | 1.960 |
Why?
|
Mesothelioma | 13 | 2022 | 301 | 1.940 |
Why?
|
Tomography, X-Ray Computed | 22 | 2022 | 2497 | 1.530 |
Why?
|
Educational Measurement | 8 | 2017 | 216 | 1.520 |
Why?
|
Internship and Residency | 7 | 2022 | 977 | 1.450 |
Why?
|
Teaching | 4 | 2014 | 145 | 1.370 |
Why?
|
Radiography | 7 | 2022 | 799 | 1.170 |
Why?
|
Pleural Neoplasms | 9 | 2022 | 184 | 1.160 |
Why?
|
Schools, Medical | 5 | 2023 | 121 | 1.060 |
Why?
|
Diagnostic Imaging | 5 | 2017 | 455 | 1.010 |
Why?
|
Surveys and Questionnaires | 10 | 2022 | 2414 | 0.850 |
Why?
|
Formative Feedback | 1 | 2021 | 12 | 0.840 |
Why?
|
Burnout, Professional | 2 | 2020 | 91 | 0.810 |
Why?
|
Peritoneal Neoplasms | 1 | 2022 | 157 | 0.790 |
Why?
|
Personnel Selection | 2 | 2017 | 59 | 0.750 |
Why?
|
Career Choice | 2 | 2017 | 138 | 0.690 |
Why?
|
Computer-Assisted Instruction | 3 | 2014 | 43 | 0.680 |
Why?
|
Interdisciplinary Communication | 1 | 2019 | 127 | 0.670 |
Why?
|
Communication | 2 | 2021 | 424 | 0.670 |
Why?
|
Mentoring | 1 | 2018 | 28 | 0.660 |
Why?
|
Workload | 1 | 2019 | 129 | 0.660 |
Why?
|
Radiology Department, Hospital | 2 | 2016 | 27 | 0.640 |
Why?
|
United States | 18 | 2022 | 6425 | 0.640 |
Why?
|
Humans | 70 | 2023 | 83873 | 0.630 |
Why?
|
Attitude of Health Personnel | 2 | 2019 | 633 | 0.580 |
Why?
|
Education, Medical, Graduate | 2 | 2017 | 358 | 0.580 |
Why?
|
Lung Neoplasms | 9 | 2022 | 2221 | 0.570 |
Why?
|
Needs Assessment | 1 | 2015 | 153 | 0.510 |
Why?
|
Biomedical Research | 1 | 2018 | 366 | 0.500 |
Why?
|
Illusions | 1 | 2013 | 11 | 0.500 |
Why?
|
Organizational Objectives | 1 | 2013 | 27 | 0.470 |
Why?
|
Faculty | 1 | 2013 | 27 | 0.470 |
Why?
|
Models, Educational | 1 | 2013 | 50 | 0.470 |
Why?
|
Classification | 1 | 2013 | 54 | 0.460 |
Why?
|
Dizziness | 1 | 2012 | 25 | 0.450 |
Why?
|
Vertigo | 1 | 2012 | 36 | 0.440 |
Why?
|
Artifacts | 2 | 2013 | 239 | 0.440 |
Why?
|
Cadaver | 1 | 2012 | 181 | 0.430 |
Why?
|
Forecasting | 1 | 2013 | 309 | 0.420 |
Why?
|
Physicians | 1 | 2019 | 647 | 0.420 |
Why?
|
Visual Perception | 1 | 2013 | 304 | 0.390 |
Why?
|
Airway Resistance | 3 | 2000 | 69 | 0.380 |
Why?
|
Ultrasonography | 4 | 2016 | 665 | 0.350 |
Why?
|
Emergency Service, Hospital | 1 | 2012 | 460 | 0.340 |
Why?
|
Male | 36 | 2019 | 40239 | 0.320 |
Why?
|
Female | 36 | 2022 | 43741 | 0.310 |
Why?
|
Clinical Competence | 3 | 2018 | 746 | 0.300 |
Why?
|
Lung | 5 | 2015 | 1124 | 0.290 |
Why?
|
Models, Biological | 1 | 2013 | 1747 | 0.290 |
Why?
|
Middle Aged | 29 | 2019 | 24691 | 0.270 |
Why?
|
Radiographic Image Enhancement | 3 | 2015 | 462 | 0.240 |
Why?
|
Radiation Protection | 1 | 2022 | 25 | 0.230 |
Why?
|
Neoplasm Staging | 5 | 2022 | 1932 | 0.230 |
Why?
|
Adult | 20 | 2018 | 25203 | 0.230 |
Why?
|
Aged, 80 and over | 16 | 2019 | 6453 | 0.220 |
Why?
|
Reproducibility of Results | 7 | 2019 | 2652 | 0.220 |
Why?
|
Radiography, Thoracic | 3 | 2014 | 320 | 0.220 |
Why?
|
Advisory Committees | 1 | 2022 | 90 | 0.220 |
Why?
|
Data Collection | 2 | 2014 | 364 | 0.220 |
Why?
|
Ascites | 1 | 2022 | 54 | 0.220 |
Why?
|
Aged | 24 | 2020 | 18098 | 0.210 |
Why?
|
Diaphragm | 3 | 2000 | 49 | 0.210 |
Why?
|
Pilot Projects | 3 | 2019 | 816 | 0.210 |
Why?
|
Phrenic Nerve | 2 | 2000 | 42 | 0.210 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 1636 | 0.210 |
Why?
|
Positron Emission Tomography Computed Tomography | 1 | 2022 | 80 | 0.210 |
Why?
|
Feedback | 1 | 2021 | 125 | 0.200 |
Why?
|
Magnetics | 2 | 1997 | 41 | 0.190 |
Why?
|
Intubation, Intratracheal | 2 | 2000 | 143 | 0.190 |
Why?
|
Papillomavirus Vaccines | 2 | 2011 | 57 | 0.190 |
Why?
|
Virtual Reality | 1 | 2020 | 21 | 0.190 |
Why?
|
Artificial Intelligence | 1 | 2022 | 251 | 0.190 |
Why?
|
Algorithms | 4 | 2015 | 1803 | 0.180 |
Why?
|
Mediastinum | 1 | 2019 | 46 | 0.180 |
Why?
|
Documentation | 1 | 2019 | 96 | 0.170 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2011 | 1188 | 0.170 |
Why?
|
Medical Records | 1 | 2019 | 119 | 0.170 |
Why?
|
Work of Breathing | 1 | 1998 | 5 | 0.170 |
Why?
|
Magnetic Resonance Imaging | 6 | 2020 | 3253 | 0.160 |
Why?
|
Ventilator Weaning | 1 | 1998 | 23 | 0.160 |
Why?
|
Respiratory Function Tests | 2 | 2017 | 133 | 0.160 |
Why?
|
Angiography | 2 | 2014 | 202 | 0.160 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2000 | 203 | 0.160 |
Why?
|
Psychometrics | 1 | 2019 | 306 | 0.160 |
Why?
|
Mammary Analogue Secretory Carcinoma | 1 | 2017 | 4 | 0.160 |
Why?
|
Streptococcus agalactiae | 1 | 1997 | 11 | 0.160 |
Why?
|
Arthritis, Infectious | 1 | 1997 | 13 | 0.160 |
Why?
|
Arthritis, Psoriatic | 1 | 1997 | 29 | 0.160 |
Why?
|
Observer Variation | 3 | 2013 | 594 | 0.160 |
Why?
|
Venous Thrombosis | 2 | 2013 | 241 | 0.160 |
Why?
|
Streptococcal Infections | 1 | 1997 | 57 | 0.150 |
Why?
|
Point-of-Care Systems | 2 | 2016 | 133 | 0.150 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2017 | 48 | 0.150 |
Why?
|
Guidelines as Topic | 2 | 2015 | 162 | 0.150 |
Why?
|
Airway Obstruction | 1 | 1998 | 108 | 0.150 |
Why?
|
Pulmonary Medicine | 1 | 2017 | 45 | 0.150 |
Why?
|
Salivary Gland Neoplasms | 1 | 2017 | 65 | 0.150 |
Why?
|
Referral and Consultation | 1 | 2019 | 321 | 0.150 |
Why?
|
Retrospective Studies | 10 | 2019 | 8061 | 0.140 |
Why?
|
Lung Diseases, Interstitial | 1 | 2019 | 222 | 0.140 |
Why?
|
Diagnosis, Differential | 3 | 2017 | 1535 | 0.140 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2016 | 65 | 0.140 |
Why?
|
Textbooks as Topic | 1 | 2015 | 2 | 0.140 |
Why?
|
Lymph Nodes | 1 | 2019 | 527 | 0.130 |
Why?
|
Congresses as Topic | 1 | 2015 | 116 | 0.130 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 2390 | 0.130 |
Why?
|
Attitude | 1 | 2015 | 122 | 0.130 |
Why?
|
Faculty, Medical | 1 | 2016 | 176 | 0.130 |
Why?
|
Learning | 1 | 2017 | 267 | 0.130 |
Why?
|
Academic Medical Centers | 1 | 2016 | 372 | 0.120 |
Why?
|
Public Opinion | 2 | 2022 | 42 | 0.110 |
Why?
|
Clinical Clerkship | 1 | 2014 | 116 | 0.110 |
Why?
|
Cerebral Cortex | 1 | 1996 | 575 | 0.110 |
Why?
|
Pulmonary Artery | 1 | 2014 | 293 | 0.110 |
Why?
|
Young Adult | 3 | 2014 | 5843 | 0.110 |
Why?
|
Societies, Medical | 1 | 2015 | 573 | 0.110 |
Why?
|
Vena Cava Filters | 1 | 2013 | 96 | 0.110 |
Why?
|
Device Removal | 1 | 2013 | 158 | 0.100 |
Why?
|
Sensitivity and Specificity | 2 | 2014 | 1967 | 0.100 |
Why?
|
Cross-Over Studies | 1 | 2012 | 396 | 0.100 |
Why?
|
Software | 2 | 2012 | 646 | 0.100 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 462 | 0.100 |
Why?
|
Gastrostomy | 2 | 2001 | 68 | 0.100 |
Why?
|
Pulmonary Embolism | 1 | 2013 | 206 | 0.100 |
Why?
|
Acute Disease | 1 | 2012 | 811 | 0.100 |
Why?
|
Hypertension, Pulmonary | 1 | 2014 | 332 | 0.100 |
Why?
|
Tumor Burden | 3 | 2016 | 278 | 0.100 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 2324 | 0.100 |
Why?
|
Electromyography | 3 | 2000 | 183 | 0.090 |
Why?
|
Mothers | 1 | 2011 | 136 | 0.090 |
Why?
|
Vaccination | 1 | 2011 | 248 | 0.090 |
Why?
|
Response Evaluation Criteria in Solid Tumors | 2 | 2019 | 57 | 0.090 |
Why?
|
Hemodynamics | 3 | 2018 | 697 | 0.090 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 1033 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2010 | 267 | 0.080 |
Why?
|
Double-Blind Method | 1 | 2012 | 1797 | 0.080 |
Why?
|
Positron-Emission Tomography | 2 | 2022 | 316 | 0.080 |
Why?
|
Papillomavirus Infections | 1 | 2010 | 243 | 0.080 |
Why?
|
Tattooing | 1 | 2007 | 6 | 0.080 |
Why?
|
Catheters, Indwelling | 2 | 2013 | 107 | 0.080 |
Why?
|
Body Piercing | 1 | 2007 | 6 | 0.080 |
Why?
|
Traumatology | 1 | 2007 | 27 | 0.080 |
Why?
|
Leadership | 2 | 2020 | 128 | 0.080 |
Why?
|
Biomarkers | 1 | 2013 | 1654 | 0.070 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2006 | 40 | 0.070 |
Why?
|
Portal Vein | 1 | 2006 | 115 | 0.070 |
Why?
|
Hyperventilation | 1 | 2005 | 13 | 0.070 |
Why?
|
Brain Stem Neoplasms | 1 | 2005 | 17 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2018 | 7776 | 0.070 |
Why?
|
Contrast Media | 1 | 2011 | 1054 | 0.070 |
Why?
|
Lymphoma, B-Cell | 1 | 2005 | 102 | 0.070 |
Why?
|
Feasibility Studies | 3 | 2016 | 741 | 0.060 |
Why?
|
Liver Cirrhosis | 1 | 2006 | 281 | 0.060 |
Why?
|
Adolescent | 7 | 2014 | 8806 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2017 | 1536 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2013 | 3603 | 0.060 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2006 | 224 | 0.060 |
Why?
|
Lung Compliance | 2 | 2000 | 14 | 0.060 |
Why?
|
Multimedia | 1 | 2022 | 8 | 0.060 |
Why?
|
Venous Pressure | 1 | 2002 | 11 | 0.060 |
Why?
|
Catheterization | 2 | 2001 | 225 | 0.060 |
Why?
|
Mentors | 1 | 2023 | 73 | 0.060 |
Why?
|
Educational Status | 1 | 2022 | 178 | 0.050 |
Why?
|
Survival Rate | 2 | 2019 | 1843 | 0.050 |
Why?
|
Respiratory Mechanics | 2 | 2000 | 100 | 0.050 |
Why?
|
Angioplasty, Balloon | 1 | 2002 | 94 | 0.050 |
Why?
|
Students | 1 | 2023 | 143 | 0.050 |
Why?
|
Prosthesis Failure | 1 | 2002 | 111 | 0.050 |
Why?
|
Perception | 1 | 2022 | 159 | 0.050 |
Why?
|
Cholangiography | 1 | 2001 | 41 | 0.050 |
Why?
|
Vascular Diseases | 1 | 2002 | 118 | 0.050 |
Why?
|
Bronchography | 1 | 2000 | 11 | 0.050 |
Why?
|
Colonic Diseases | 1 | 2001 | 70 | 0.050 |
Why?
|
Suction | 1 | 2000 | 34 | 0.050 |
Why?
|
Nuclear Family | 2 | 2011 | 91 | 0.050 |
Why?
|
Bronchoconstriction | 1 | 2000 | 55 | 0.050 |
Why?
|
Ultrasonography, Interventional | 1 | 2001 | 110 | 0.050 |
Why?
|
Blood Vessel Prosthesis | 1 | 2002 | 221 | 0.050 |
Why?
|
Technology | 1 | 2020 | 26 | 0.050 |
Why?
|
Wakefulness | 1 | 2000 | 131 | 0.050 |
Why?
|
Electric Stimulation | 1 | 2000 | 340 | 0.050 |
Why?
|
Embolization, Therapeutic | 1 | 2001 | 214 | 0.040 |
Why?
|
Positive-Pressure Respiration | 1 | 1999 | 40 | 0.040 |
Why?
|
Muscle Contraction | 2 | 1997 | 284 | 0.040 |
Why?
|
Renal Dialysis | 1 | 2002 | 339 | 0.040 |
Why?
|
Fellowships and Scholarships | 1 | 2020 | 104 | 0.040 |
Why?
|
Transducers, Pressure | 1 | 1998 | 6 | 0.040 |
Why?
|
Lung Volume Measurements | 2 | 2013 | 19 | 0.040 |
Why?
|
Tidal Volume | 1 | 1998 | 53 | 0.040 |
Why?
|
Tomography, Spiral Computed | 1 | 2018 | 74 | 0.040 |
Why?
|
Acoustics | 1 | 1998 | 48 | 0.040 |
Why?
|
Physician-Patient Relations | 1 | 2023 | 602 | 0.040 |
Why?
|
Neck Muscles | 1 | 1997 | 15 | 0.040 |
Why?
|
Mouth | 1 | 1997 | 48 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 11 | 0.040 |
Why?
|
Myoepithelioma | 1 | 2017 | 11 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2017 | 24 | 0.040 |
Why?
|
Illinois | 1 | 2019 | 459 | 0.040 |
Why?
|
Bone and Bones | 1 | 1999 | 257 | 0.040 |
Why?
|
France | 1 | 2017 | 46 | 0.040 |
Why?
|
Parotid Gland | 1 | 2017 | 31 | 0.040 |
Why?
|
Evoked Potentials, Motor | 1 | 1996 | 16 | 0.040 |
Why?
|
Job Application | 1 | 2016 | 8 | 0.040 |
Why?
|
Breast Neoplasms | 1 | 2010 | 2831 | 0.040 |
Why?
|
Neural Conduction | 1 | 1996 | 69 | 0.040 |
Why?
|
Thumb | 1 | 1996 | 22 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 104 | 0.040 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2017 | 62 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1998 | 201 | 0.040 |
Why?
|
School Admission Criteria | 1 | 2016 | 22 | 0.040 |
Why?
|
Time Factors | 2 | 2013 | 5176 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2017 | 290 | 0.040 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2017 | 129 | 0.040 |
Why?
|
Gene Rearrangement | 1 | 2017 | 169 | 0.040 |
Why?
|
Translocation, Genetic | 1 | 2017 | 265 | 0.040 |
Why?
|
Internal Medicine | 1 | 2020 | 341 | 0.040 |
Why?
|
Respiration | 1 | 1998 | 255 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2018 | 338 | 0.040 |
Why?
|
Pyrazoles | 1 | 2017 | 152 | 0.040 |
Why?
|
Consumer Behavior | 1 | 2015 | 29 | 0.040 |
Why?
|
Reaction Time | 1 | 1996 | 305 | 0.030 |
Why?
|
Pyridines | 1 | 2017 | 305 | 0.030 |
Why?
|
Prognosis | 2 | 2013 | 3618 | 0.030 |
Why?
|
Neural Pathways | 1 | 1996 | 296 | 0.030 |
Why?
|
Mobile Applications | 1 | 2015 | 55 | 0.030 |
Why?
|
Edema | 1 | 2014 | 69 | 0.030 |
Why?
|
Color | 1 | 2014 | 78 | 0.030 |
Why?
|
Radiation, Ionizing | 1 | 2014 | 120 | 0.030 |
Why?
|
Hot Temperature | 1 | 2014 | 203 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 580 | 0.030 |
Why?
|
Prospective Studies | 3 | 2013 | 4090 | 0.030 |
Why?
|
Sampling Studies | 1 | 2013 | 70 | 0.030 |
Why?
|
Phlebography | 1 | 2013 | 65 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2014 | 488 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2015 | 266 | 0.030 |
Why?
|
Rabbits | 1 | 2014 | 634 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 422 | 0.030 |
Why?
|
Regression Analysis | 1 | 2014 | 596 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2015 | 479 | 0.030 |
Why?
|
Liver Transplantation | 1 | 2001 | 1239 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2017 | 1736 | 0.030 |
Why?
|
Pemetrexed | 1 | 2012 | 76 | 0.030 |
Why?
|
Glutamates | 1 | 2012 | 89 | 0.030 |
Why?
|
Disease Progression | 1 | 2017 | 1478 | 0.030 |
Why?
|
Fractals | 1 | 2012 | 43 | 0.030 |
Why?
|
Logistic Models | 1 | 2016 | 1157 | 0.030 |
Why?
|
Fourier Analysis | 1 | 2012 | 126 | 0.030 |
Why?
|
Cohort Studies | 1 | 2019 | 2703 | 0.030 |
Why?
|
Catheterization, Central Venous | 1 | 2013 | 116 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2013 | 270 | 0.030 |
Why?
|
ROC Curve | 1 | 2014 | 743 | 0.030 |
Why?
|
Reference Standards | 1 | 2012 | 154 | 0.030 |
Why?
|
Guanine | 1 | 2012 | 206 | 0.030 |
Why?
|
Deoxycytidine | 1 | 2012 | 236 | 0.030 |
Why?
|
Suburban Population | 1 | 2010 | 5 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2014 | 438 | 0.030 |
Why?
|
Michigan | 1 | 2010 | 48 | 0.030 |
Why?
|
Parity | 1 | 2010 | 93 | 0.020 |
Why?
|
Fluoroscopy | 2 | 2001 | 117 | 0.020 |
Why?
|
Biopsy | 1 | 2014 | 1139 | 0.020 |
Why?
|
Cisplatin | 1 | 2012 | 600 | 0.020 |
Why?
|
Health Surveys | 1 | 2010 | 236 | 0.020 |
Why?
|
Urban Population | 1 | 2010 | 212 | 0.020 |
Why?
|
Child | 2 | 2011 | 6706 | 0.020 |
Why?
|
Animals | 3 | 2015 | 26005 | 0.020 |
Why?
|
Mammography | 1 | 2010 | 457 | 0.020 |
Why?
|
Nursing Assessment | 1 | 2007 | 19 | 0.020 |
Why?
|
Esophageal and Gastric Varices | 1 | 2006 | 33 | 0.020 |
Why?
|
Risk Assessment | 1 | 2013 | 2223 | 0.020 |
Why?
|
Biomarkers, Tumor | 1 | 2013 | 1441 | 0.020 |
Why?
|
Pregnancy | 1 | 2010 | 2795 | 0.020 |
Why?
|
Renal Veins | 1 | 2002 | 27 | 0.010 |
Why?
|
Retreatment | 1 | 2002 | 107 | 0.010 |
Why?
|
Vena Cava, Superior | 1 | 2002 | 59 | 0.010 |
Why?
|
Angiography, Digital Subtraction | 1 | 2002 | 87 | 0.010 |
Why?
|
Intubation, Gastrointestinal | 1 | 2001 | 31 | 0.010 |
Why?
|
Constriction, Pathologic | 1 | 2002 | 205 | 0.010 |
Why?
|
Needles | 1 | 2001 | 33 | 0.010 |
Why?
|
Pulmonary Atelectasis | 1 | 2000 | 17 | 0.010 |
Why?
|
Pulmonary Gas Exchange | 1 | 2000 | 31 | 0.010 |
Why?
|
Sheep | 1 | 2000 | 227 | 0.010 |
Why?
|
Stomach | 1 | 2000 | 109 | 0.010 |
Why?
|
Equipment Design | 1 | 2000 | 404 | 0.010 |
Why?
|
Respiratory Paralysis | 1 | 1997 | 8 | 0.010 |
Why?
|
Hypertrophy | 1 | 1997 | 62 | 0.010 |
Why?
|
Electrodes | 1 | 1997 | 77 | 0.010 |
Why?
|
Pressure | 1 | 1997 | 160 | 0.010 |
Why?
|
Neck | 1 | 1997 | 98 | 0.010 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 1997 | 179 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2001 | 1753 | 0.010 |
Why?
|
Oxygen | 1 | 2000 | 721 | 0.010 |
Why?
|
Child, Preschool | 1 | 2001 | 3569 | 0.010 |
Why?
|